🗣Reiersen = “RAY-er-sen”
🧠Psychiatrist ➡️
🦠COVID scientist💊🩺
********📰LATEST NEWS📰********
*SJCAPP paper on psychiatric diagnoses and medications in Wolfram Syndrome: https://sciendo.com/article/10.2478/sjcapp-2022-0017#
*We are recruiting long haulers in Missouri & Illinois for our Fluvoxamine LONG COVID TRIAL. See flyer on my Instagram, FB, or X (formerly twitter) account .
*************************************
🥼Co-PI, “STOP COVID” trials:
💊fluvoxamine vs placebo for prevention of
🫁respiratory deterioration in outpatients
🦠with COVID19 (OFF-LABEL USE)
💊fluvoxamine LONG COVID trial is now IN PROGRESS.
ℹ️👨⚕️👩🏽💻💁🏻♀️👨🏾⚕️🧑🏿⚕️
HEALTHY MIND LAB:
🌐https://healthymind.wustl.edu
🩺👩🏽⚕️A good review paper:
📙Facente SN, et al., 2021
📚PMID: 34851510
🎥 Includes video abstract❣️
📰💊Fluvoxamine (FLV) COVID19 News:
📈 Together Trial (Brazil) FLV results:
💠~32% ⬇️ hospitalization risk!
For those taking 80% of pills:
💠~66% ⬇️ hospitalization risk!
💠~91% ⬇️ mortality risk!
📄LANCET GLOBAL HEALTH 10/27/21📚PMID: 34717820
📓STOP COVID 1 results:
🌐https://jamanetwork.com/journals/jama/fullarticle/2773108
📓Article on fluvoxamine mechanisms in COVID19:
🌐https://www.frontiersin.org/articles/10.3389/fphar.2021.652688/full
📓STOP COVID 2 results:
🌐https://academic.oup.com/ofid/article/10/8/ofad419/7238414
📰📰 NEWS articles about 📰📰
📰STOP COVID 1 & STOP COVID 2📰
(Search: source + fluvoxamine + COVID)
🗞LA TImes (Lopez)
🗞Washington Post (Klausner)
🗞Health Affairs Blog (Sukhatme & Sukhatme)
🗞Scientific American (Schmidt)
🗞CNN (Cohen, Gupta & Kane)
🗞Cerebrum (Reiersen)
📺⏱CBS/60Minutes (3/7/21)⏱
https://www.cbsnews.com/news/covid-19-repurposed-drugs-60-minutes-2021-03-07/
📔Relevant research article PMIDs📔
(Search PubMed for these PMIDs)
📚33180097📚32271506📚33403480
📚 33392622📚32522674📚32975484
📚33163980📚33560374📚34050932
📚34851510📚34717820📚34385600
👩🏫Associate Professor of Psychiatry
🎓Washington University in St. Louis
⚕️School of Medicine
🌐https://psychiatry.wustl.edu
👩🔬📊🧬Research Interests:
•neurodevelopmental disorders
•schizophrenia
•genetics
•Wolfram syndrome /endoplasmic reticulum disorders
•epidemiology
•COVID-19 (drug repurposing)
💠💠💠💠Opinions are my own. 💠💠💠💠
⚠️⚠️Educational content & other information given on Clubhouse is not medical advice. ⚠️⚠️
🔆🔅🔆🔅🔆🔅🔆🔅🔆🔅🔆🔅🔆🔅🔆🔅
♣️World Mental Health 🌏 🧠
♣️2nd Time Around (2TA)💊♻️
(Drug repurposing club)
Invited by: Scott Muir, MD
if the data has not been changed, no new rows will appear.
Day | Followers | Gain | % Gain |
---|---|---|---|
June 29, 2024 | 6,533 | +22 | +0.4% |
May 27, 2024 | 6,511 | +3 | +0.1% |
April 24, 2024 | 6,508 | +33 | +0.6% |
March 16, 2024 | 6,475 | +17 | +0.3% |
February 23, 2024 | 6,458 | +14 | +0.3% |
February 06, 2024 | 6,444 | +19 | +0.3% |
January 19, 2024 | 6,425 | +15 | +0.3% |
January 03, 2024 | 6,410 | +13 | +0.3% |
December 18, 2023 | 6,397 | +14 | +0.3% |
December 03, 2023 | 6,383 | +19 | +0.3% |